Cargando…
Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus
Type 2 diabetes mellitus (T2DM) and metabolic syndrome contribute to hypertriglyceridemia, which may increase residual risk of cardiovascular disease in patients with elevated triglyceride (TG) levels despite optimal low-density lipoprotein cholesterol (LDL-C) levels with statin therapy. Prescriptio...
Autores principales: | Tajuddin, Nadeem, Shaikh, Ali, Hassan, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846047/ https://www.ncbi.nlm.nih.gov/pubmed/27143943 http://dx.doi.org/10.2147/DMSO.S97036 |
Ejemplares similares
-
Retrospective Case Series of Patients with Diabetes or Prediabetes Who Were Switched from Omega-3-Acid Ethyl Esters to Icosapent Ethyl
por: Hassan, Amir, et al.
Publicado: (2014) -
Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)
por: Brinton, Eliot A., et al.
Publicado: (2017) -
Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products
por: Fialkow, Jonathan
Publicado: (2016) -
Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link?
por: Hegazy, Mona, et al.
Publicado: (2019) -
Omega 3 Fatty Acids vs Omega 6 Fatty Acids
por: Feliu, María, et al.
Publicado: (2022)